253 related articles for article (PubMed ID: 12888501)
1. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.
Kretschmer-Kazemi Far R; Sczakiel G
Nucleic Acids Res; 2003 Aug; 31(15):4417-24. PubMed ID: 12888501
[TBL] [Abstract][Full Text] [Related]
2. Local RNA target structure influences siRNA efficacy: a systematic global analysis.
Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I
J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019
[TBL] [Abstract][Full Text] [Related]
3. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
4. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
5. The activity of siRNA in mammalian cells is related to the kinetics of siRNA-target recognition in vitro: mechanistic implications.
Wünsche W; Sczakiel G
J Mol Biol; 2005 Jan; 345(2):203-9. PubMed ID: 15571715
[TBL] [Abstract][Full Text] [Related]
6. Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis.
Graef T; Steidl U; Nedbal W; Rohr U; Fenk R; Haas R; Kronenwett R
Angiogenesis; 2005; 8(4):361-72. PubMed ID: 16400518
[TBL] [Abstract][Full Text] [Related]
7. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions.
Schubert S; Grünweller A; Erdmann VA; Kurreck J
J Mol Biol; 2005 May; 348(4):883-93. PubMed ID: 15843020
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.
Grünweller A; Wyszko E; Bieber B; Jahnel R; Erdmann VA; Kurreck J
Nucleic Acids Res; 2003 Jun; 31(12):3185-93. PubMed ID: 12799446
[TBL] [Abstract][Full Text] [Related]
9. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
[TBL] [Abstract][Full Text] [Related]
10. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
[TBL] [Abstract][Full Text] [Related]
11. Technical improvements in the computational target search for antisense oligonucleotides.
Far RK; Leppert J; Frank K; Sczakiel G
Oligonucleotides; 2005; 15(3):223-33. PubMed ID: 16201910
[TBL] [Abstract][Full Text] [Related]
12. The potency of siRNA-mediated growth inhibition following silencing of essential genes is dependent on siRNA design and varies with target sequence.
Patel R; T'wallant NC; Herbert MH; White D; Murison JG; Reid G
Oligonucleotides; 2009 Dec; 19(4):317-28. PubMed ID: 19943803
[TBL] [Abstract][Full Text] [Related]
13. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
[TBL] [Abstract][Full Text] [Related]
14. Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.
Dyer PDR; Shepherd TR; Gollings AS; Shorter SA; Gorringe-Pattrick MAM; Tang CK; Cattoz BN; Baillie L; Griffiths PC; Richardson SCW
J Control Release; 2015 Dec; 220(Pt A):316-328. PubMed ID: 26546271
[TBL] [Abstract][Full Text] [Related]
15. Effects of local mRNA structure on posttranscriptional gene silencing.
Rudnick SI; Swaminathan J; Sumaroka M; Liebhaber S; Gewirtz AM
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13787-92. PubMed ID: 18784366
[TBL] [Abstract][Full Text] [Related]
16. Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells.
Dutkiewicz M; Ojdowska A; Kuczynski J; Lindig V; Zeichhardt H; Kurreck J; Ciesiołka J
PLoS One; 2015; 10(8):e0136395. PubMed ID: 26308932
[TBL] [Abstract][Full Text] [Related]
17. Expressing functional siRNAs in mammalian cells using convergent transcription.
Tran N; Cairns MJ; Dawes IW; Arndt GM
BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
[TBL] [Abstract][Full Text] [Related]
18. A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability.
Patzel V; Steidl U; Kronenwett R; Haas R; Sczakiel G
Nucleic Acids Res; 1999 Nov; 27(22):4328-34. PubMed ID: 10536139
[TBL] [Abstract][Full Text] [Related]
19. Silencing efficacy prediction: a retrospective study on target mRNA features.
Pascut D; Bedogni G; Tiribelli C
Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25702798
[TBL] [Abstract][Full Text] [Related]
20. Concepts to automate the theoretical design of effective antisense oligonucleotides.
Far RK; Nedbal W; Sczakiel G
Bioinformatics; 2001 Nov; 17(11):1058-61. PubMed ID: 11724735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
